Łupińska Anna, Aszkiełowicz Sara, Zygmunt Arkadiusz, Lewiński Andrzej, Stawerska Renata
Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.
Department of Pediatric Endocrinology, Medical University of Lodz, 93-338 Lodz, Poland.
J Clin Med. 2025 Apr 25;14(9):2988. doi: 10.3390/jcm14092988.
: The skeletal system reaches peak bone mass through modeling and remodeling processes, influenced by environmental, dietary, hormonal, and genetic factors. In children with endocrinopathies, disturbances in bone mass and mineralization may correlate with hormonal levels, but conditions like short stature or obesity can confound DXA results. This study aimed to assess the prevalence of decreased bone mineral density (BMD) in children with endocrine disorders and evaluate the impact of auxological and hormonal abnormalities on BMD. This study analyzed medical records of 148 children (mean age 11.85 ± 3.34 years); 73 girls and 75 boys). Conditions included obesity (22.9%), short stature (47.9%), precocious puberty (10.1%), and other diagnoses. Clinical data included primary diagnosis, height, body weight, pubertal stage, and serum concentrations of calcium, phosphate, alkaline phosphatase, 25OHD, PTH, osteocalcin, Crosslaps, TSH, fT4, IGF-1, IGF-BP3, cortisol, estradiol, testosterone, and bone age. DXA scans were performed at the total body less head (TBLH) and lumbar spine (Spine) projection. Low bone mass (aBMD Z-score ≤ -2) was found in 34.46% at TBLH and 15.54% at the Spine. After height adjustment (HAZ adjustment), the prevalence of low bone mass decreased to 11.4% at TBLH and 4.1% at the Spine. In the short stature group, the normalization of Z-scores for height significantly reduced abnormal results. A positive correlation was found between DXA parameters and age, height standard deviation score (HSDS), BMI SDS, estradiol, testosterone, IGF-1, and IGF-BP3. A negative correlation existed between vitamin D and DXA parameters. Bone turnover markers (osteocalcin and Crosslaps) also negatively affected bone mass. No significant correlations were found with PTH, TSH, fT4, or cortisol. In children with growth retardation, lower aBMD Z-scores were observed in those with decreased IGF-1. Positive correlations existed between BMI SDS, IGF-1, and adjusted aBMD Z-scores. Children with endocrine disorders, especially those with short stature, are at risk for bone mineralization disorders. Height normalization is crucial for accurate DXA interpretation and avoiding overdiagnosis. Positive influences on bone mass include height, BMI, IGF-1, estradiol, and testosterone, while negative factors include bone turnover markers and low vitamin D.
骨骼系统通过塑形和重塑过程达到骨量峰值,这一过程受环境、饮食、激素和遗传因素影响。在内分泌疾病患儿中,骨量和矿化的紊乱可能与激素水平相关,但身材矮小或肥胖等情况可能会混淆双能X线吸收法(DXA)的结果。本研究旨在评估内分泌疾病患儿骨密度(BMD)降低的患病率,并评估体格学和激素异常对BMD的影响。本研究分析了148名儿童(平均年龄11.85±3.34岁;73名女孩和75名男孩)的病历。疾病包括肥胖(22.9%)、身材矮小(47.9%)、性早熟(10.1%)及其他诊断。临床数据包括初步诊断、身高、体重、青春期阶段以及血清钙、磷、碱性磷酸酶、25羟维生素D、甲状旁腺激素、骨钙素、I型胶原交联羧基末端肽、促甲状腺激素、游离甲状腺素、胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子结合蛋白3(IGF-BP3)、皮质醇、雌二醇、睾酮和骨龄。在全身除头部(TBLH)和腰椎(脊柱)部位进行DXA扫描。发现TBLH部位骨量低(aBMD Z值≤-2)的比例为34.46%,脊柱部位为15.54%。经身高调整(身高Z值调整)后,TBLH部位骨量低的患病率降至11.4%,脊柱部位降至4.1%。在身材矮小组中,身高Z值的正常化显著减少了异常结果。发现DXA参数与年龄、身高标准差评分(HSDS)、体重指数标准差评分(BMI SDS)、雌二醇、睾酮、IGF-1和IGF-BP3之间呈正相关。维生素D与DXA参数之间呈负相关。骨转换标志物(骨钙素和I型胶原交联羧基末端肽)也对骨量有负面影响。未发现与甲状旁腺激素、促甲状腺激素、游离甲状腺素或皮质醇有显著相关性。在生长发育迟缓的儿童中,IGF-1降低者的aBMD Z值较低。BMI SDS、IGF-1与调整后的aBMD Z值之间呈正相关。内分泌疾病患儿,尤其是身材矮小的患儿,有发生骨矿化障碍的风险。身高正常化对于准确解读DXA结果和避免过度诊断至关重要。对骨量有积极影响的因素包括身高、BMI、IGF-1、雌二醇和睾酮,而消极因素包括骨转换标志物和低维生素D。